Last reviewed · How we verify

NCT07147816

Cervical Transcutaneous SCS for TBI

Terminated NA Last updated 9 February 2026
What this trial tests

NA trial testing Transcutaneous electrical stimulation of the cervical spinal cord (tSCS) in Traumatic Brain Injury in 14 participants. Terminated before completion.

Timeline
26 November 2025
Primary endpoint
29 January 2026
29 January 2026

Quick facts

Lead sponsorRoberto de Freitas
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment14
Start date26 November 2025
Primary completion29 January 2026
Estimated completion29 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Roberto de Freitas

Who can join

Adults 21 to 70, any sex, with Traumatic Brain Injury or TBI (Traumatic Brain Injury). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to test the effects of non-invasive electrical stimulation of the spinal cord (called transcutaneous spinal cord stimulation, or tSCS) on arm and hand movement in people with motor impairments after a traumatic brain injury (TBI). Specifically, tSCS will be delivered using adhesive electrode pads placed on the skin over the upper back. The research team will measure how tSCS affects strength, movement control and muscle spasticity using different tests. Results of this study will help develop future treatments using an implanted (invasive) form of spinal cord stimulation to improve arm and hand function, helping people with TBI become more independent and improve their quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07147816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing